LABU - Direxion Daily Biotech Bull 3X Shares ETF. Fund Details. Fund Type Miscellaneous. Issuer Direxion Funds. Inception 05/28/2015. Expense Ratio 1.01%. AUM $1.23B # of Holdings 145 *Holdings as ...

LABU is 3X leveraged fund that has disappointed the biotech bulls. It can work for medium term returns if two requirements are met. See more on this ETF here.

LABU represents an opportunity for short-term speculation on U.S. biotechnology stocks. It is a daily leveraged ETF and should not be held for even moderate periods of time due to its high market ...

As of April 8, 2021, LABU had $508.1 million in assets under management. The fund is advised by Rafferty Asset Management LLC and charges an annual net expense ratio of 1.02%, ...

LABU fell to the $5.97 flat lower trendline but collapsed through March 2023 as shares reached a new swing low of $4.57. Pullback support levels are at $4.57, $4.06, $3.40, and $2.52.

Although LABU is already up almost 46 percent this month, the ETF remains appealing on a technical basis, indicating it could deliver more near-term upside for risk-tolerant traders.

Nasdaq provides after market quotes of stock trades from 4:00 P.M. EST to 8:00 P.M. EST. After Hours participation from Market Makers and ECNs is strictly voluntary. Investors who anticipate ...

View Historical Risk Statistics for Direxion Daily S&P Biotech Bull 3X Shares (LABU).

LABU Portfolio - Learn more about the Direxion Daily S&P Biotech Bull 3X ETF investment portfolio including asset allocation, stock style, stock holdings and more.

LABU Performance - Review the performance history of the Direxion Daily S&P Biotech Bull 3X ETF to see it's current status, yearly returns, and dividend history.